Western blot analysis revealed that AKT, p-AKT, and SREBP1 were markedly decreased by overexpressing RBP7 in HR + BC cells, demonstrating that RBP7 reduced fatty acid content by inhibiting the AKT/SREBP1 pathway (Fig. 6d). The gene discussed is RBP7; the disease is breast cancer.